India Pharma Outlook Team | Tuesday, 02 September 2025
Novo Nordisk and Apollo Clinics have signed a strategic partnership to provide a comprehensive obesity control program in multiple Indian cities.
Through a structured, multi-tiered care strategy centered on empowering people with overweight or obesity and creating specialized programs for obesity care, this project seeks to alleviate the rising burden of overweight and obesity.
Apollo Clinics and Novo Nordisk will put in place a comprehensive obesity, healthcare ecosystem together and at select Apollo Clinics.
As part of this partnership Apollo Clinics will lend its vast experience as a pioneer in condition management programmes and will provide support like infrastructure, clinical pathways, and digital patient support tools to provide evidence-based obesity care.
There will also be dedicated patient awareness campaigns, which will include awareness videos, awareness booklets, and body composition assessment. And through a QR-enabled platform, we will provide individual access to BMI and waist-to-height ratio calculator and the ability to connect them to respective care pathways.
Also Read: Eli Lilly Launches Mounjaro Pen in India to Tackle Diabetes, Obesity
Dr Maya Sharma, vice president, clinical, medical & regulatory, Novo Nordisk India; said, "The prevalence of obesity continues to raise in India, yet clinical recognition remains inadequate. Novo Nordisk aims to transform how obesity is understood, diagnosed and managed at the primary level across the nation.
The mission of this partnership with Apollo Clinics is to equip healthcare professionals with robust clinical education, patient-centric tools and infrastructure support they need to deliver personalised and evidence-based healthcare interventions that go beyond symptom management.
Together, we hope to drive lasting behavioural and health outcomes, ultimately improving quality of life for millions of Indians living with overweight or obesity."
